Loading, please wait...
This CE will provide pharmacists with the knowledge of current hepatitis C treatment guidelines and the pharmacology, adverse reactions, and drug interactions associated with these therapies.
Fee
$8.00
CE Hours
1.00
CE Units
0.100
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
|
Shenandoah University Bernard J. Dunn School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
To receive credit the following items must be completed
1. Register for the event through supharmacy.learningexpressce.com
2. Attend the entire activity
3. Complete all relevant learning assessments
4. Complete an activity evaluation through supharmacy.learningexpressce.com
Support/Credits
No external funding has been obtained for this activity. The speakers have no conflicts of interest to disclose.
Objectives
- Identify patients who are at risk of contracting hepatitis C
- Explain the pathophysiology of chronic hepatitis C.
- Describe the pharmacology of the direct acting antivirals used to treat chronic hepatitis C.
- Discuss the most common drug interactions associated with hepatitis C treatments.
Speaker(s)/Author(s)
|
Staci Eastin |
Activity Number
0101-0000-22-016-H01-P
Release Date:
Nov 15, 2022
Credit Expiration Date:
Nov 15, 2025
CE Hours
1.00